je.st
news
Tag: merck
Jury finds for Merck in hepatitis drug fight with Gilead
2016-03-23 00:19:12| Biotech - Topix.net
A federal jury in California has ruled in favor of drugmaker Merck in a high-stakes lawsuit against rival Gilead Sciences concerning patents for lucrative new drugs for hepatitis C. Merck accused Gilead of infringing on patents it filed over a decade ago, claiming Gilead's sofosbuvir infringes on those patents. Sofosbuvir is the active ingredient in Gilead's Sovaldi and a component of its Harvoni, which together brought in $19.1 billion last year.
Merck Animal Health awards $170,000 in scholarships to veterinary students
2016-03-17 15:19:57| National Hog Farmer
Merck Animal Health, in partnership with the American Veterinary Medical Foundation (AVMF), today announced the recipients of the 2016 Merck Animal Health Veterinary Student Scholarship Program. Through this program, 34 exemplary second- and third-year veterinary students from around the world will each receive a $5,000 scholarship. All are pursuing future careers in either large animal or companion animal medicine. read more
Tags: health
students
awards
animal
Merck Demands $3 Billion In HCV Royalties From Gilead
2016-03-11 20:20:18| Biotech - Topix.net
Merck wants to Bogart a $3B royalty payment equal to 10% of the $31.7B Gilead has made from HCV sales. Gilead has had a target on its back from regulators, competitors and politicians ever since its blockbuster HCV regimen hit the market.
Tags: billion
demands
merck
royalties
Merck Applauds the U.S. Department of Veterans Affairs (VA) for Broadening Treatment Access for Veterans with Chronic Hepatitis C Infection
2016-03-09 22:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, applauds the U.S. Department of Veterans Affairs (VA) for broadening access to treatment for Veterans with chronic hepatitis C virus (HCV) infection. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
access
department
treatment
Private Wealth Partners LLC Decreases Position in Merck & Co., Inc.
2016-03-09 09:48:46| Biotech - Topix.net
Private Wealth Partners LLC cut its stake in shares of Merck & Co., Inc. by 0.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 211,948 shares of the company's stock after selling 189 shares during the period.
Tags: inc
private
position
partners
Sites : [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] next »